Provided by Tiger Trade Technology Pte. Ltd.

UNITED LAB

8.850
-0.220-2.43%
Volume:5.98M
Turnover:52.87M
Market Cap:17.46B
PE:6.92
High:9.150
Open:9.150
Low:8.770
Close:9.070
52wk High:17.774
52wk Low:8.420
Shares:1.97B
HK Float Shares:1.97B
Volume Ratio:0.81
T/O Rate:0.30%
Dividend:0.49
Dividend Rate:5.49%
EPS(LYR):1.279
ROE:13.04%
ROA:4.89%
PB:0.87
PE(LYR):6.92
PS:1.14

Loading ...

United Lab Keeps Share Capital Steady at 1.97 Billion Shares in May; Public Float Above 25%

Bulletin Express
·
Jun 02

BRIEF-United Laboratories International Says China NMPA Approves Clinical Trial Of Unit's TUL108

Reuters
·
May 19

United Laboratories Unit Gets China Nod for Infection Drug Trial

MT Newswires Live
·
May 19

UNITED LAB's Investigational Antibiotic TUL108 Receives China NMPA Clearance for Clinical Trials

Stock News
·
May 19

United Laboratories International - China National Medical Products Administration Approves Clinical Trial of Unit's Tul108 for Injection

THOMSON REUTERS
·
May 19

United Labs says China regulator clears TUL108 injection for clinical trial

Reuters
·
May 19

United Laboratories Updates Board Composition and Committee Line-Up

Bulletin Express
·
May 15

BRIEF-United Laboratories International Says Zhu Su Yan Resigns As Executive Director

Reuters
·
May 15

TUL files director list with Hong Kong Stock Exchange

Reuters
·
May 15

UNITED LAB Executive Director Ms. Zhu Su Yan to Step Down on 15 May 2026

Bulletin Express
·
May 15

United Laboratories executive director Zhu Suyan resigns effective May 15, 2026

Reuters
·
May 15

United Laboratories International - Zhu SU Yan Resigns as Executive Director Effective 15 May 2026

THOMSON REUTERS
·
May 15

Federal Pharmaceutical Rises Over 3% in Intraday Trading as Weekly Long-Acting Insulin Candidate UBT38006 Injection Receives Clinical Trial Approval

Deep News
·
May 08

United Laboratories Unit Gets China Nod for Insulin Product Trial

MT Newswires Live
·
May 07

AI Frenzy Shifts from Hardware to Applications, Musk-Related Concepts Gain Traction

Stock News
·
May 07

BRIEF-United Laboratories International Says China's NMPA Approves Clinical Trial Application For UBT38006 Injection

Reuters
·
May 07

UNITED LAB's UBT38006 Injection Receives Implied Clinical Trial Approval

Stock News
·
May 07

United Labs says China regulator clears UBT38006 weekly insulin for clinical trial

Reuters
·
May 07

United Laboratories International - China National Medical Products Administration Approves Clinical Trial Application for Ubt38006 Injection

THOMSON REUTERS
·
May 07

Assessing United Laboratories International Holdings (SEHK:3933) Valuation After Dupilumab Biosimilar Trial Approval

Simply Wall St.
·
May 07